NSABP Foundation Inc.
Beth Ann Ferrara has extensive experience in the healthcare sector, primarily in clinical trial management and oncology care. Currently serving as an Operational Study Manager at PRA Health Sciences since July 2019, Ferrara also holds the position of Clinical Trial Manager at NSABP Foundation Inc. since July 2012, where responsibilities include overseeing complex multicenter breast and colorectal cancer trials from protocol development to final reporting. Previously, Ferrara managed the Oral Oncology Cycle Management Program at Walgreens Specialty Pharmacy, LLC, and coordinated patient care in melanoma, head and neck cancer, and sarcoma at Hillman Cancer Center. Early career experience includes serving as a staff nurse at AHN Allegheny General Hospital. Ferrara obtained a Bachelor’s Degree in Registered Nursing from Waynesburg University.
NSABP Foundation Inc.
Partners in Cancer Research… The NSABP Foundation is a not-for-profit academic research organization with a nearly 60-year history of conducting ground-breaking research studies in breast and colorectal cancer. Our goal is to improve outcomes for cancer patients via improved therapeutic and prevention modalities. Over the past 15 years we have established full-service capabilities to conduct independently funded international research with the private sector to evaluate promising new agents and now offer a wide range of capabilities, from pre-clinical research through phase III clinical trials focused on biomarker-driven studies. In its history the NSABP has enrolled more than 110,000 women and men in clinical trials in breast and colorectal cancer. We have research sites at nearly 700 major medical centers, university hospitals, large oncology practice groups, and health maintenance organizations in the United States, Canada, and Ireland. At those sites and their satellites, about 5000 physicians, nurses, and other medical professionals conduct NSABP treatment and prevention trials. The NSABP Foundation, located at Nova Place in Pittsburgh, Pennsylvania, carries on the legacy of the National Surgical Adjuvant Breast and Bowel Project in clinical studies done in partnership with industry.